DL-Histidine

DL-Histidine is an amino acid featuring an imidazole side chain that can participate in acid-base equilibria and metal coordination, paired with a primary amino group and a carboxylic acid functionality. The molecule exists as a racemic mixture of stereoisomers at the α-carbon, which is relevant for chiral method development and for establishing stereochemical effects in peptide and enzyme contexts. Histidine's imidazole ring enables nucleophilic participation in derivatization reactions and can undergo protection strategies when orthogonal functional group chemistry is required. The free amino acid form also serves as a practical starting material for converting the carboxyl group to activated esters or protected acids and for preparing peptide-compatible derivatives used in synthetic organic chemistry and biochemical research workflows.

1. Peptide Coupling

DL-Histidine is applied in peptide synthesis workflows where the α-amino and carboxylate functionalities enable standard amide bond formation after appropriate activation. The imidazole side chain can be managed through protection strategies to prevent side reactions during coupling and subsequent deprotection steps, supporting controlled incorporation into peptide building blocks. Racemic DL-Histidine can be used for generating stereochemically mixed peptide libraries for method development, assay optimization, or non-stereospecific scaffold studies. Downstream peptide analogs prepared from histidine derivatives can be used to probe sequence effects and to support fragment assembly in synthetic peptide chemistry.

2. Side-Chain Functionalization

DL-Histidine is utilized for amino acid derivatization and side-chain chemistry driven by the imidazole ring's nucleophilicity and protonation-dependent reactivity. The presence of both an α-amino group and a carboxylic acid allows selective conversion into protected amino acid derivatives or amino acid ester intermediates, enabling orthogonal functional group transformations. Imidazole-directed modifications can generate conjugation handles, metal-binding motifs, or reactive intermediates suitable for subsequent coupling to biomolecules or synthetic scaffolds. Resulting histidine-functionalized products can serve as intermediates for peptidomimetics, coordination complexes, and chemical biology probes.

3. Chemical Biology Probes

DL-Histidine is applied in chemical biology and biochemical research contexts where histidine-containing motifs participate in enzyme active-site recognition, metal binding, and pH-responsive behavior. The imidazole side chain can be incorporated into peptide fragments, protein labeling reagents, or immobilized ligands to study binding interactions and conformational effects under varying protonation states. Racemic incorporation may be used when stereochemical specificity is not the primary variable, such as in screening-style studies or in constructing mixed stereoisomer standards for analytical method development. Histidine-based constructs derived from DL-Histidine can also function as reference materials for monitoring imidazole-dependent reactivity in biochemical assays.

4. Analytical Standards Development

DL-Histidine is suitable for analytical research and method validation where amino acid composition, stereochemical identity, and imidazole-containing functionality require reliable reference materials. The free amino acid format supports preparation of derivatized standards for chromatographic detection, including derivatization routes that target the α-amino group and preserve the imidazole for characteristic response. Racemic DL-Histidine can be employed to generate calibration materials for assays that quantify total histidine content without stereospecific separation. Histidine-derived analytical intermediates can further support identification workflows for peptide hydrolysates and for monitoring synthetic conversion in amino acid derivative production.

5. Pharmaceutical Intermediate Synthesis

DL-Histidine is used in pharmaceutical intermediate preparation and fine chemical synthesis as a chiral amino acid precursor that can be converted into protected amino acid derivatives and activated carboxyl derivatives for downstream coupling chemistry. The α-amino and carboxyl groups enable manufacturing-relevant transformations such as N-protection and carboxyl activation, while the imidazole side chain can be protected or selectively functionalized depending on the target scaffold. Racemic starting material can be applied for process development stages where stereochemical resolution occurs later or where stereochemical mixing is acceptable for intermediate generation. Histidine-derived intermediates can feed into the construction of medicinal chemistry fragments, peptidomimetic motifs, and heteroatom-rich scaffolds used in synthetic organic chemistry.

6. Industrial Biocatalysis Substrates

DL-Histidine is employed as a substrate or feedstock for industrial biocatalysis and chemical manufacturing routes that involve amino acid transformation, enzymatic derivatization, or process-compatible conversion to protected intermediates. The imidazole side chain provides a functional handle for enzyme recognition and for forming downstream conjugation-ready derivatives after controlled protection and deprotection sequences. Racemic DL-Histidine can be used in process development where enzyme selectivity and stereochemical outcome are evaluated as part of route design. Histidine-derived products generated from such workflows can serve as intermediates for specialty chemical production and for manufacturing of histidine-containing building blocks used across applied chemistry programs.

1. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

4. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics